Web Analytics

3 Latest Announced Rounds

  • $10,500,000
    Series A

    6 Investors

    Chemical Manufacturing
    Nov 15th, 2024
  • $3,000,000
    Pre-Seed

    1 Investors

    Software Development
    Nov 15th, 2024
  • $68,070,000
    Series D

    5 Investors

    Financial Services
    Nov 15th, 2024
$1,373.04M Raised in 70 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Phase Genomics

start up
United States - Seattle, Washington
  • 06/03/2024
  • Unknown
  • $1,500,000

Phase Genomics applies Hi-C and other proximity-ligation methods to enable chromosome-scale genome assembly, metagenomic deconvolution, as well as analysis of structural genomic variation and genome architecture. They offer a comprehensive portfolio of laboratory and computational services and products, including Hi-C kits for plants, animals, microbes, and human samples as well as industry-leading genome and metagenome assembly and analysis software.
Founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs, the company’s mission is to empower scientists with state-of-the-art genomic tools that will accelerate breakthrough discoveries. The company serves academic and commercial researchers in diverse fields and industries.


Related People

Ivan Liachko 🇺🇦Co Founder

Ivan Liachko 🇺🇦 United States - Seattle, Washington

A molecular geneticist/genomicist with over two decades of experience in wet-lab and computational biology. Founder and CEO of Seattle-based Phase Genomics Inc. (est. 2015). Passionate about applying genomic technology to improve our world and mentoring scientists interested in commercialization.

**Citations on Google Scholar*: https://scholar.google.com/citations?user=VBQJ1-gAAAAJ&hl=en
**Other Publications & News*: https://phasegenomics.com/publications/